View this article online: https://www.claimsjournal.com/news/southeast/2009/08/26/103237.htm
Eli Lilly & Co. will pay $22.5 million to settle a federal lawsuit filed by the West Virginia Attorney General’s Office over the popular anti-psychotic drug Zyprexa.
In the settlement, the Indianapolis-based company agreed to pay $15.75 million to West Virginia and $6.75 million to lawyers who represented the state.
The settlement says $14.75 million will be used to fund behavioral health care, and the remaining $1 million will go to consumer protection.
Lilly didn’t acknowledge wrongdoing. West Virginia had claimed the company improperly marketed the drug.
Lilly settled a lawsuit over Zyprexa involving 30 states in January for $1.42 billion. The company still faces lawsuits in 11 other states.
U.S. District Judge Jack Weinstein in Brooklyn, N.Y., approved West Virginia’s settlement in late July.